Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2 | F54991-0.4ML

Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2 | F54991-0.4ML | Gentaur US, UK & Europe Disrtribition

Family: Primary antibody

Formulation: In 1X PBS, pH 7.4, with 0.09% sodium azide

Format: Purified

Clone: N/A

Host Animal: Rabbit

Clonality: Polyclonal (rabbit origin)

Species Reactivity: Human

Application: WB, FACS, IHC-P

Buffer: N/A

Limitation: This Mitochondrial amidoxime reducing component 2 antibody is available for research use only.

Purity: Antigen affinity purified

Description: Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.

Immunogen: A portion of amino acids 270-300 from the human protein was used as the immunogen for the Mitochondrial amidoxime reducing component 2 antibody.

Storage: Aliquot the Mitochondrial amidoxime reducing component 2 antibody and store frozen at -20 °C or colder. Avoid repeated freeze-thaw cycles.